180 related articles for article (PubMed ID: 27498064)
21. DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics.
Guimarães LM; Baumhoer D; Andrei V; Friedel D; Koelsche C; Gomez RS; von Deimling A; Gomes CC
J Pathol Clin Res; 2023 Nov; 9(6):464-474. PubMed ID: 37555357
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of NFATc1 in giant cell lesions of the jaws, cherubism and brown tumor of hyperparathyroidism.
Duarte AP; Gomes CC; Gomez RS; Amaral FR
Oncol Lett; 2011 May; 2(3):571-573. PubMed ID: 22866121
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.
Lietman SA; Kalinchinko N; Deng X; Kohanski R; Levine MA
Hum Mutat; 2006 Jul; 27(7):717-8. PubMed ID: 16786512
[TBL] [Abstract][Full Text] [Related]
24. Cherubism: a differential diagnosis of multinucleate giant cell lesions of jaw.
Bindu S; Mulay S; Kulkarni D
Indian J Pathol Microbiol; 2001 Oct; 44(4):489-90. PubMed ID: 12035376
[No Abstract] [Full Text] [Related]
25. Cherubism and its charlatans.
Lannon DA; Earley MJ
Br J Plast Surg; 2001 Dec; 54(8):708-11. PubMed ID: 11728115
[TBL] [Abstract][Full Text] [Related]
26. Jawing about TNF: new hope for cherubism.
Novack DV; Faccio R
Cell; 2007 Jan; 128(1):15-7. PubMed ID: 17218248
[TBL] [Abstract][Full Text] [Related]
27. Giant cell reparative granuloma of the orbit associated with cherubism.
Font RL; Blanco G; Soparkar CN; Patrinely JR; Ostrowski ML
Ophthalmology; 2003 Sep; 110(9):1846-9. PubMed ID: 13129888
[TBL] [Abstract][Full Text] [Related]
28. Cherubism--a case report with long term follow up.
Chavali LV; Bhimalingam RM; Sudhakar PV
Indian J Pathol Microbiol; 2011; 54(4):793-5. PubMed ID: 22234113
[TBL] [Abstract][Full Text] [Related]
29. [Nonfamilial cherubism. A clinical case report].
Benetti C; Crippa R; Mazza M; Bassetti E
Minerva Stomatol; 1995 Mar; 44(3):119-26. PubMed ID: 7623753
[TBL] [Abstract][Full Text] [Related]
30. Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism.
Carvalho VM; Perdigão PF; Amaral FR; de Souza PE; De Marco L; Gomez RS
Oral Dis; 2009 Jan; 15(1):106-10. PubMed ID: 19017279
[TBL] [Abstract][Full Text] [Related]
31. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
[TBL] [Abstract][Full Text] [Related]
32. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
33. Characterization of multinucleated giant cells in synovium and subchondral bone in knee osteoarthritis and rheumatoid arthritis.
Prieto-Potin I; Largo R; Roman-Blas JA; Herrero-Beaumont G; Walsh DA
BMC Musculoskelet Disord; 2015 Aug; 16():226. PubMed ID: 26311062
[TBL] [Abstract][Full Text] [Related]
34. ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.
Jeong BC; Kim JH; Kim K; Kim I; Seong S; Kim N
Bone; 2017 Feb; 95():33-40. PubMed ID: 27829167
[TBL] [Abstract][Full Text] [Related]
35. Cherubism. A case report.
Cariati P; Monsalve Iglesias F; Fernández Solís J; Valencia Laseca A; Martinez Lara I
Reumatol Clin; 2017; 13(6):352-353. PubMed ID: 27427211
[TBL] [Abstract][Full Text] [Related]
36. [Gene mutation and expression of SH-3BP-2 in cherubism].
Li YW; Meng XM; Yu SF; Gao P
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Apr; 44(4):227-31. PubMed ID: 19576004
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of argyrophilic nuclear organizer regions in giant cell lesions of jaws.
Sadri D; Hejazi M; Jahanbani J; Forouzandeh A
J Oral Pathol Med; 2010 May; 39(5):431-4. PubMed ID: 20202088
[TBL] [Abstract][Full Text] [Related]
38. Effects of pulsed electromagnetic fields on the expression of NFATc1 and CAII in mouse osteoclast-like cells.
He J; Zhang Y; Chen J; Zheng S; Huang H; Dong X
Aging Clin Exp Res; 2015 Feb; 27(1):13-9. PubMed ID: 24869857
[TBL] [Abstract][Full Text] [Related]
39. Decoy receptor 3 suppresses RANKL-induced osteoclastogenesis via down-regulating NFATc1 and enhancing cell apoptosis.
Cheng CP; Sheu MJ; Sytwu HK; Chang DM
Rheumatology (Oxford); 2013 Apr; 52(4):609-22. PubMed ID: 23221330
[TBL] [Abstract][Full Text] [Related]
40. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
